Inventor · disambiguated record
Qibin Su
Also filed as: SU QIBIN
8 granted patents·9 pending applications·19 citations·filing 2007–2025
83Inventor score
Files withASTRAZENECA AB12DIZAL JIANGSU PHARMACEUTICAL CO LTD3CHUAQUI CLAUDIO EDMUNDO1ZENTAUR THERAPEUTICS USA INC1
Top patents by PatentIndex Score
17 records- 0188US9714236B2Compounds and methods for inhibiting JAKASTRAZENECA AB·Filed 2016·Granted Jul 25, 2017·6 cites·5 claims
- 0287US10961228B2JAK1 selective inhibitorsASTRAZENECA AB·Filed 2018·Granted Mar 30, 2021·3 cites·21 claims
- 0386US11247983B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 15, 2022·2 cites·19 claims
- 0486US10167276B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 1, 2019·5 cites·5 claims
- 0585US12473272B2JAK1 selective inhibitorsASTRAZENECA AB·Filed 2023·Granted Nov 18, 2025·0 cites·9 claims
- 0684US10654835B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2018·Granted May 19, 2020·3 cites·22 claims
- 0773US11897869B2JAK1 selective inhibitorsASTRAZENECA AB·Filed 2021·Granted Feb 13, 2024·0 cites·24 claims
- 0868US2024247001A12,6,9-trisubstituted purinesASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0964US12441744B22,6,9-trisubstituted purinesASTRAZENECA AB·Filed 2025·Granted Oct 14, 2025·0 cites·19 claims
- 1061US2024092779A1Usp1 inhibitors and uses thereofZENTAUR THERAPEUTICS USA INC·Filed 2023·Application pending·0 cites
- 1153US2011201628A1Heterocyclic jak kinase inhibitorsCHUAQUI CLAUDIO EDMUNDO·Filed 2009·Application pending·0 cites
- 1249US2015051185A1Chemical Compounds 251ASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1347US2010311748A1Heterocyclic amides useful for the treatment of cancer and psoriasisASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1446US2010029643A1Heterocyclyc sulfonamides having edg-1 antagonistic activityASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1544US2009111860A1Sulfonamide compounds useful as adg receptor modulatorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1643US2009105324A1Imidazole derivatives for use as edg-1 antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1742US2010197749A1Chemical compoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qibin Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →